Off-Label Marketing Case Settled by Pfizer for $55M

For off-label marketing of the drug Protonix and other fraudulent conduct, Pfizer has agreed to pay $55 million in its settlement with the United States Department of Justice. Protonix is an acid reflex drug produced by Wyeth, which is owned by Pfizer. Off-label marketing “Wyeth tried to cheat the system by obtaining a limited FDA approval for Protonix, fully intending to promote this drug for additional, unapproved uses,” stated U.S. Attorney Carmen Ortiz. The Food and Drug Administration only approved Protonix for a particular kind of gastro-esophageal reflux disease (GERD)...

read more

Facebook